Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 474-480

  Tang, San Yuan ^a   Zhong, Mei Zuo ^b   Yuan, Guang Jin ^c   Hou, Su Ping ^d   Yin, Lei Lan ^a   Jiang, Hao ^a   Yu, Zheng Yang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Cancer Center   (China)

^d HARRISON INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Apoptosis; Casticin; Cell surface receptor; Colon cancer; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

CASTICIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DECOY RECEPTOR 2; FLAVONOID; FLICE INHIBITORY PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SMALL INTERFERING RNA; SURVIVIN; TUMOR NECROSIS FACTOR DECOY RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANALYSIS OF VARIANCE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; COLONIC NEOPLASMS; DOWN-REGULATION; FLAVONOIDS; GENE SILENCING; GPI-LINKED PROTEINS; HCT116 CELLS; HT29 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR DECOY RECEPTORS; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84872825981     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2127     Document Type: Article

References (32)

1. MacFarlane M: TRAIL-induced signalling and apoptosis. Toxicol Lett 139: 89-97, 2003. (Pubitemid 36298966)
2. Pan G, Ni J, Wei YF, Yu G, Gentz R and Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818, 1997. (Pubitemid 27366732)
3. Emery JG, McDonnell P, Burke MB, et al: Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273: 14363-14367, 1998. (Pubitemid 28319153)
4. Mellier G, Huang S, Shenoy K and Pervaiz S: TRAILing death in cancer. Mol Aspects Med 31: 93-112, 2010.
5. Zhang L and Fang B: Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 12: 228-237, 2005. (Pubitemid 40315182)
6. Rieger J, Frank B, Weller M and Wick W: Mechanisms of resistance of human glioma cells to Apo2 ligand/TNF-related apoptosis-inducing ligand. Cell Physiol Biochem 20: 23-34, 2007. (Pubitemid 46956809)
7. Kurbanov BM, Fecker LF, Geilen CC, Sterry W and Eberle J: Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. Oncogene 26: 3364-3377, 2007. (Pubitemid 46788891)
8. Jung EM, Lim JH, Lee TJ, Park JW, Choi KS and Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26: 1905-1913, 2005. (Pubitemid 41631263)
9. Prasad S, Ravindran J, Sung B, Pandey MK and Aggarwal BB: Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins. Mol Cancer Ther 9: 856-868, 2010.
10. Sung B, Ravindran J, Prasad S, Pandey MK and Aggarwal BB: Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. J Biol Chem 285: 35418-35427, 2010.
11. Siegelin MD, Reuss DE, Habel A, Herold-Mende C and von Deimling A: The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol Cancer Ther 7: 3566-3574, 2008.
12. Koh DJ, Ahn HS, Chung HS, et al: Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-kappaB inactivation. J Ethnopharmacol 136: 399-405, 2011.
13. Choudhary MI, Jalil S, Nawaz SA, Khan KM and Tareen RB: Antiinflammatory and lipoxygenase inhibitory compounds from Vitex agnus-castus. Phytother Res 23: 1336-1339, 2009.
14. Mesaik MA, Murad S, Khan KM, Tareen RB, Ahmed A and Choudhary MI: Isolation and immunomodulatory properties of a flavonoid, casticin from Vitex agnus-castus. Phytother Res 23: 1516-1520, 2009.
15. Csupor-Loffler B, Hajdu Z, Zupko I, et al: Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s.l. on cultured human tumour cell lines. Phytother Res 23: 672-676, 2009.
16. Haidara K, Zamir L, Shi QW and Batist G: The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett 242: 180-190, 2006. (Pubitemid 44485312)
17. Kobayakawa J, Sato-Nishimori F, Moriyasu M and Matsukawa Y: G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne file). Cancer Lett 208: 59-64, 2004. (Pubitemid 38501784)
18. Shen JK, Du HP, Yang M, Wang YG and Jin J: Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol 88: 743-752, 2009.
19. Yang J, Yang Y, Tian L, Sheng XF, Liu F and Cao JG: Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroenterol 17: 4298 - 4307, 2011.
20. Cao JG, Peng SP, Sun L, Li H, Wang L and Deng HW: Vascular basement membrane-derived multifunctional peptide, a novel inhibitor of angiogenesis and tumor growth. Acta Biochim Biophys Sin 38: 514-521, 2006. (Pubitemid 44091744)
21. Yang XH, Zheng X, Cao JG, Xiang HL, Liu F and Lv Y: 8-Bromo-7- methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol 16: 3385-3393, 2010.
22. Fulda S, Meyer E and Debatin KM: Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21: 2283-2294, 2002. (Pubitemid 34407288)
23. Song JJ, An JY, Kwon YT and Lee YJ: Evidence for two modes of development of acquired tumor necrosis factor-related apoptosis-inducing ligand resistance. Involvement of Bcl-xL. J Biol Chem 282: 319-328, 2007. (Pubitemid 47076650)
24. Azuhata T, Scott D, Griffith TS, Miller M and Sandler AD: Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. J Pediatr Surg 41: 1431-1440, 2006. (Pubitemid 44080254)
25. Siegelin MD, Gaiser T and Siegelin Y: The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Neurochem Int 55: 423-430, 2009.
26. Kwon D, Choi K, Choi C and Benveniste EN: Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Biochem Biophys Res Commun 372: 870-874, 2008.
27. Yodkeeree S, Sung B, Limtrakul P and Aggarwal BB: Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species. Cancer Res 69: 6581-6589, 2009.
28. Ola MS, Nawaz M and Ahsan H: Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351: 41-58, 2011.
29. Altieri DC: Survivin and IAP proteins in cell-death mechanisms. Biochem J 430: 199-205, 2010.
30. Safa AR and Pollok KE: Targeting the anti-apoptotic protein c-FLIP for cancer therapy. Cancers 3: 1639-1671, 2011.
31. Bradley JR and Pober JS: Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20: 6482-6491, 2001. (Pubitemid 32977853)
32. Kim H, Kim EH, Eom YW, et al: Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res 66: 1740-1750, 2006. (Pubitemid 43259959)